MedPath
NMPA Approval

Ripertamab Injection

国药准字S20220024

August 23, 2022

Drug Information

瑞帕妥单抗注射液

安平希

注射剂

100mg(10ml)/瓶

生物制品

August 23, 2022

Company Information

Applicant Company

北京市北京经济技术开发区科创七街31号院5号楼301室

Manufacturing Company

北京市大兴区北京经济技术开发区科创七街31号院

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

瑞帕妥单抗注射液 - NMPA 批准文号 | MedPath